Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The present study is a randomized, control, phase II study of locally advanced nasopharyngeal
carcinoma (NPC) treated with Gemcitabine plus cisplatin regimen (GP) or Docetaxel，cisplatin
regimen plus 5-Fluorouracil (TPF) induction chemotherapy followed by concurrent
chemoradiotherapy.